Evert B. Schimmelpennink, Director of Contineum Therapeutics CTNM, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $251.4K. The latest trade was on 06/26.

ES

ES

Evert B. Schimmelpennink

Director

Company

Contineum Therapeutics CTNM

First filing

24/03/25

Trades

16 trades

Buys / sales

1 / 0

12-month net buying

$251.4K

Last trade

06/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Lenz TherapeuticsLENZ	Open-market buy	03/27	03/30	28,089 sh	$8.95	$251,396.55	+57.1%